Graphene nano-ribbon based high potential and efficiency for DNA, cancer therapy and drug delivery applications.
Nano ribbon
PEGylated
anti-cancer
drug delivery
gene therapy
Journal
Drug metabolism reviews
ISSN: 1097-9883
Titre abrégé: Drug Metab Rev
Pays: England
ID NLM: 0322067
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
pubmed:
21
2
2019
medline:
31
12
2019
entrez:
21
2
2019
Statut:
ppublish
Résumé
In this article, graphene oxide Nano ribbons (GONRs) and its high potential for using in medical fields have been reviewed. Recently, Graphene Nano ribbons (GNRs) has been a field of interest in biological methods and disease treatment such as drug delivery, DNA applications, and photothermal cancer therapies. GNRs demonstrate more efficient properties rather than other graphene-based Nanomaterials due to their larger surface area. These novel properties made them into a remarkable substitute material for biological fields as they have different cytotoxic effects and almost nontoxic to human health and the environment. In this study, some of the significant effects of GNRs such as Geno toxicity effects in human mesenchymal stem cells, DNA assembly, drug delivery agents, and the use of PEGylated GNRs in photothermal cancer therapy has been investigated.
Identifiants
pubmed: 30784324
doi: 10.1080/03602532.2019.1582661
doi:
Substances chimiques
graphene oxide
0
Graphite
7782-42-5
DNA
9007-49-2
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM